Grote Zaal, 1st Floor Thursday, May 4, 12:15 – 13:45 |
Management of early-stage HCC: current unmet needs and rationale for neoadjuvant and adjuvant immunotherapy-based approaches |
12:15–12:25 | WELCOME AND INTRODUCTION TO HCC, Gonzalo Sapisochin, MD, Toronto, Canada |
12:25–12:40 | CURRENT MANAGEMENT OF EARLY-STAGE AND INTERMEDIATE-STAGE HCC, Albert Chan, MD, Hong Kong |
12:40–13:00 | IMMUNOTHERAPY IN HCC: CURRENT LANDSCAPE AND POTENTIAL RATIONALE FOR NOVEL NEOADJUVANT AND ADJUVANT APPROACHES, Sherrie Bhoori, MD, Milan, Italy |
13:00–13:15 | CASE-STUDY DISCUSSION: MANAGEMENT OF HCC POTENTIALLY ELIGIBLE FOR TRANSPLANT, Parissa Tabrizian, MD, New York, USA |
13:15–13:30 | CASE-STUDY DISCUSSION: MANAGEMENT OF HCC THAT IS BORDERLINE MILAN CRITERIA, Gonzalo Sapisochin, MD, Toronto, Canada |
13:30–13:45 | AUDIENCE Q&A, Gonzalo Sapisochin, MD, Toronto, Canada |
Jurriaanse Zaal, 1st Floor Thursday, May 4, 15:15 – 16:15 |
Thriving post transplant – shaping the environment and therapy for long term success |
15:15-15:25 | Welcome and introductory remarks – Prof. Herold J Metselaar (Chair) Erasmus MC, Gastroenterology & Hepatology, Netherlands |
15:25-15:40 | Artificial intelligence and liver transplantation – Dr. Javier Briceño, Hospital Universitario Reina Sofía, Spain |
15:40-15:55 | Current and future aspects of liver preservation and re-conditioning – Dr Alexandre Chebaro, CHU Rennes University Hospital, France |
15:55-16:10 | The importance of maintaining adequate tacrolimus levels. What’s new? – Dr. Rodríguez-Perálvarez, Hospital Universitario Reina Sofía, Spain |
16:10-16:15 | Concluding remarks – Prof. Herold J Metselaar (Chair) |
Van Weelde Zaal, 4th Floor Thursday, May 4, 15:15 – 16:15 |
Liver Ex Situ Perfusion: A paradigm shift in organ ex situ management |
15:15-15:20 | Welcome Introduction (Chairs) |
15:20-15:40 | The Temperature: Beyond the dualism Hypothermia vs Normothermia – Robert J Porte, Rotterdam, Netherlands |
15:40-15:50 | Ex Situ Liver Perfusion: Clinical Results – Irene, Scalera, Bari, Italy |
15:50-16:00 | Inflammation Treatment in Liver Ex Situ Perfusion – Davide, Ghinolfi, Pisa, Italy |
16:00-16:15 | Final Discussion |
Building the new standard of care – The OCS Liver Program
Grote Zaal, 1st Floor |
1. The OCS Liver National OCS Program (NOP): structure and process – Malcolm MacConmara |
2. Experience and Outcomes from using the OCS Liver NOP – Gabe Schnickel |
3. NOP: Expanding transplant center volume – single center experience – Amit Mathur |
4. Transforming practices: benefits for the patient and the transplant center – Andrew Barbas |
5. Beyond the first 1,000 OCS Livers NOP cases: what is next? – Magdy Attia |
6. Q&A |
*Moderators: Marwan Abouljoud and Liz Pomfret |
Grote Zaal, 1st Floor Friday, May 5, 12:30 – 13:30 |
Utilization of blood-based biomarkers in liver transplant patients; a step closer to personalized medicine |
Eduard Flipse Zaal, 1st Floor Friday, May 5, 12:30 – 13:30 |
Normothermic Perfusion: Why, When and How? |
12:30 – 12:35 | Symposium Open – Peter Friend, MD, FRC S, OrganOx Chief Medical Officer, OrganOx, Oxford, United Kingdom |
12:35 – 12:50 | Normothermic Perfusion: Why, When And How? – Stefan Shcneeberger, MD, MBA, FEBS (Director, Head of Transplantation surgery and Hepatobiliary Surgery, Innsbruck Medical University, Austria |
12:50 – 13:05 | Normothermic Perfusion: Why, When And How? – Transplant Surgeon, Mount Sinai, New York. |
13:05 – 13:20 | Normothermic Perfusion: Why, When And How? – Transplant Surgeon, Cleveland Clinic, Ohio |
13:20 – 13:30 | Q&A Discussion and Symposium Close |
Eduard Flipse Zaal, 1st Floor Friday, May 5, 13:45 – 15:00 |
Unlock the power of flexibility for liver perfusion |
13:50-14:10 | Implementing a successful machine perfusion program – The Munich experience – Dr. Moritz Drefs, LMU Klinikum Munchen, Munchen, Germany; Dr. Dionysios Koliogiannis, LMU Klinikum Munchen, Munchen, Germany |
14:10-14:35 | Machine perfusion, from cold to warm – The Groningen experience – Prof. Vincent de Meijer, UMC Groningen, Groningen, The Netherlands |
14:35-14:55 | Using ex-situ machine perfusion to test new therapeutics – Dr. Fotios Sampaziotis, University of Cambridge, Cambridge, United Kingdom |
* Moderator: Prof. Umberto Cillo Università di Padova, Padova, Italy |